One-Shot Gene Edit Slashes Cholesterol As Cleveland Lab Rethinks Alzheimer’s
Interim data show a single infusion of a PCSK9 base editor sharply lowered LDL in an early trial, while Cleveland researchers link low nitric oxide to altered gene splicing in Alzheimer’s. Clinicians warned that supplements aren’t regulated like drugs and can carry risks.
